Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results.

BACKGROUND Barrett's esophagus is a premalignant lesion for esophageal adenocarcinoma. This study tests the hypothesis that re-injury of the metaplastic the epithelium in an acid-controlled environment will result in reversal of Barrett's to squamous epithelium. METHODS Patients with at least 2 cm of Barrett's esophagus were treated with omeprazole, and half the circumference of the Barrett's was treated with multipolar electrocoagulation (MPEC); the other half served as an internal control. After 6 months, the remaining Barrett's esophagus was treated with MPEC. RESULTS Twenty-four hour esophageal pH of less than 4 averaged 1.8% on a mean dose of 56 mg/day of omeprazole. Ten patients had visual and biopsy elimination of the targeted section of Barrett's esophagus after an average of 2.5 MPEC sessions. The remainder of the Barrett's esophagus is being treated in 9 patients; currently 5 have no evidence of Barrett's. CONCLUSIONS The combination of control of esophageal acid exposure and reinjury of the metaplastic epithelium reverses Barrett's esophagus to squamous epithelium as determined by endoscopy and biopsy.

[1]  J. Peters,et al.  Is Barrett's metaplasia the source of adenocarcinomas of the cardia? , 1994, Archives of surgery.

[2]  M Panjehpour,et al.  Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. , 1993, Gastrointestinal endoscopy.

[3]  Mark A. Laukka,et al.  Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. , 1995, Gastrointestinal endoscopy.

[4]  J. Fraumeni,et al.  Continuing climb in rates of esophageal adenocarcinoma: an update. , 1993, JAMA.

[5]  L. Brandt,et al.  Repeat laser therapy of recurrent Barrett's epithelium: success with anacidity. , 1995, Gastrointestinal endoscopy.

[6]  R. Sampliner.  Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. , 1994, The American journal of gastroenterology.

[7]  Johnson Lf,et al.  Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. , 1974 .

[8]  A R Zinsmeister,et al.  Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. , 1993, Gastroenterology.

[9]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[10]  B. Overholt,et al.  Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer. , 1995 .

[11]  W. Samowitz,et al.  Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. , 1993, Gastroenterology.

[12]  N. Shepherd,et al.  Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy , 1993, Alimentary pharmacology & therapeutics.

[13]  F. Ellis,et al.  Effect of antireflux operation on Barrett's mucosa. , 1990, The Annals of thoracic surgery.